In AD human brain tissue, ESRα co-localized with neurofibrillary pathology, and their interaction interrupted estrogen signaling, demonstrating that sequestration of ESRα by tau pathology decreased the neuroprotective role of estrogen in AD [104]. This evidence concerns the gene MAPT and Alzheimer disease.